Canaccord Genuity Maintains a 'Buy' on Solazyme (SZYM); Q4 preview: Minding the Milestones

February 17, 2012 10:20 AM EST Send to a Friend
Get Alerts SZYM Hot Sheet
Price: $2.36 -10.94%

Rating Summary:
    6 Buy, 6 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 3 | Down: 17 | New: 2
Trade SZYM Now!
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Solazyme (NASDAQ: SZYM) price target of $19.00.

Analyst, John Quealy, said, "SZYM will report Q4/11 results on February 21 after the close (call at 4:30pm ET). We model revs/EPS at $15.0M/$(0.16) vs. consensus at $15.1M/$(0.16). We find financial results to be less meaningful than progress vs. key milestones (detailed on following page) at this point (third quarterly call post IPO)."

"We expect funded research partnership programs to continue to account for the majority of sales this quarter, with ramping Algenist sales driving increased product revenues. We look for additional progress finalizing feedstock/offtake contracts, including additional details on the Roquette European sales agreement for algal flour."

For an analyst ratings summary and ratings history on Solazyme click here. For more ratings news on Solazyme click here.

Shares of Solazyme closed at $12.18 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View

Related Entities

Earnings

Add Your Comment